Chemicals In Your Breath Could Reveal Lung Cancer, New Research Says

Jan 28 2014, 8:12pm CST | by

Chemicals In Your Breath Could Reveal Lung Cancer, New Research Says

A simple breath test for lung cancer got a step closer to reality today with research showing that specific compounds in the breath can indicate the presence or absence of lung cancer. Findings presented to the Society of Thoracic Surgeons 50th annual meeting showed that high-tech sensors can detect specific compounds in the breath released by lung cancer cells.

Michael Bousamra, M.D. and a team of researchers from the University of Louisville developed a silicone microprocessor and mass spectrometer that showed 95-percent accuracy in detecting specific volatile organic compounds (VOCs) associated with lung cancer. Called carbonyls, and more specifically aldehydes and ketones, these compounds produced by the body and can present a type of metabolic signature for lung cancer and other types of cancer.

Bousamra and colleagues gave the breath test to patients who already had suspicious tumors that had been detected by CT scans. Then they matched the breathalyzer findings with biopsy and clinical data. For patients whose breath contained elevated levels of three or four VOCs associated with cancer, the breath test was 95 percent accurate in predicting their tumors would turn out to be malignant, the researchers said.

The opposite also proved true. When participants’ breath did not contain the cancer-specific carbonyls, the test was 80 percent accurate in predicting that their tumors would turn out to be benign.

The researchers cautioned that their data are preliminary and have yet to be published in a peer-reviewed journal. However, there’s ample evidence to support the idea that cancer cells release specific organic compounds in the breath that can indicate the presence of a tumor.

For example, in 2012, a team of researchers from the Winship Cancer Institute at Emory University presented findings to the American Society of Clinical Oncology (ASCO), published in the Journal of Clinical Oncology, showing that 75 specific VOCs were significantly different in the breath of patients with lung cancer vs. those who were cancer-free. The Emory University researchers employed a device developed by the Georgia Tech Research Institute.

Another study published in 2012 identified colon cancer with more than 80-percent accuracy using 15 previously identified VOCs.

In fact, the race to perfect and prove a breath test for cancer is on around the country, with numerous research teams working to identify cancer-specific patterns of VOCs and to develop devices sensitive enough to accurately measure their presence.

And no wonder. Lung cancer is the deadliest cancer of all, killing more people than breast, prostate and colon cancer combined, according to the American Lung Association. One of the primary reasons lung cancer is so deadly is that it’s typically caught at a late stage, when it’s already begun to spread, or metastasize. Stage I lung cancer has a 70-percent cure rate, but by stage III or later fewer than 25 percent of cases can be cured. Hence the importance of developing tests that can detect lung tumors early.

Mountain View, California-based Metabolomx may be the furthest along in the race to bring a cancer breath test to market. The company’s colorimetric sensor, which detects and measures VOCs using 36 different chemically reactive colorants, is being tested in trials at the Cleveland Clinic’s Respiratory Institute.

Using Metabolomx’s sensor technology, Peter Mazzone, MD, director of the Institute’s lung cancer program, published research and presented findings at the American College of Chest Physicians Annual Meeting (CHEST 2013) showing that VOCs in exhaled breath could provide a “metabolic biosignature” that was 75-percent accurate in identifying compounds associated with lung tumors.

Metabolomx reports that the company has launched new trials in partnership with the Cleveland Clinic using a next-generation sensor that’s 100 times more accurate.

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Oops! US Airways Didn't Mean To Post THAT Tweet
Oops! US Airways Didn't Mean To Post THAT Tweet
US Airways has been left red-faced after posting an embarrassing tweet on its official Twitter account. The error is the latest in a line of gaffes by different companies on social media, highlighting the problems many...
 
 
A Lucky Drug Made Pharmacyclics' Robert Duggan A Billionaire. Will Long-Term Success Follow?
A Lucky Drug Made Pharmacyclics' Robert Duggan A Billionaire. Will Long-Term Success Follow?
Robert Duggan was enjoying just your average Tampa vacation–a visit to the headquarters of the Church of Scientology, to which he’s a major donor, and a double date with one of the world’s top supermodels–when a board...
 
 
Emerging Markets: Separating The Sheep And The Goats
Investors who thought emerging markets were the bee’s knees have suffered agonizing reappraisals. After several years of Federal Reserve-fueled rallies, less developed markets are now in the doldrums. Emerging economies...
 
 
Tencent WeChat and SINA Weibo: The Frenemies of the Chinese Mobile Space
Tencent WeChat and SINA Weibo: The Frenemies of the Chinese Mobile Space
Once the darling of tech investors, Sina (NASDAQ: SINA) Weibo failed to excite Asian investors during its pre-IPO investor education in Hong Kong last week. Sina is expected to spin off its Weibo social networking...
 
 
 

Latest from the Network

Oops! US Airways Didn't Mean To Post THAT Tweet
US Airways has been left red-faced after posting an embarrassing tweet on its official Twitter account. The error is the latest in a line of gaffes by different companies on social media, highlighting the problems many...
Read more on Business Balla
 
A Lucky Drug Made Pharmacyclics' Robert Duggan A Billionaire. Will Long-Term Success Follow?
Robert Duggan was enjoying just your average Tampa vacation–a visit to the headquarters of the Church of Scientology, to which he’s a major donor, and a double date with one of the world’s top supermodels–when a board...
Read more on Business Balla
 
Emerging Markets: Separating The Sheep And The Goats
Investors who thought emerging markets were the bee’s knees have suffered agonizing reappraisals. After several years of Federal Reserve-fueled rallies, less developed markets are now in the doldrums. Emerging economies...
Read more on Business Balla
 
Tencent WeChat and SINA Weibo: The Frenemies of the Chinese Mobile Space
Once the darling of tech investors, Sina (NASDAQ: SINA) Weibo failed to excite Asian investors during its pre-IPO investor education in Hong Kong last week. Sina is expected to spin off its Weibo social networking...
Read more on Business Balla
 
Voices From The Vineyard: Fado Singing In The Duoro Valley
This series, Voices from the Vineyard, shines a light on the people who actually do the work — the physical labor — of making wine in the field. Though it is often overlooked in favor of the winemaking part of the...
Read more on Business Balla
 
The Next Big Business Buzzword: Ecosystem?
Words are funny things.  Business words are even funnier. That’s because, in actuality, there aren’t that many new business ideas.  Most of the time, we just slap new labels onto old things.  For example, your “core...
Read more on Business Balla
 
Has Healthcare Embraced A Hit-And-Run Strategy?
Sovaldi is off to the races — the biggest and most successful drug launch, by far, in the history of the industry. This is a truly remarkable achievement, a combination of derring-do and flawless execution that has...
Read more on Business Balla
 
Energy Companies Need To Remake Their Boards, Before Activists Force Them To
This is a guest article written by Steven Goodman, Roger Aguirre and Avery Marcus in the Global Energy Practice of Egon Zehnder. The firm specializes in CEO and senior-level executive search, board consulting and...
Read more on Business Balla
 
Court rejects bankruptcy protection for Mt. Gox
TOKYO (AP) — The Mt. Gox bitcoin exchange in Tokyo is headed for liquidation after a court rejected its bankruptcy protection application. Mt. Gox said Wednesday the Tokyo District Court decided the...
Read more on Business Balla
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla